Axcella Health Stock Revenue
Axcella Health fundamentals help investors to digest information that contributes to Axcella Health's financial success or failures. It also enables traders to predict the movement of Axcella Stock. The fundamental analysis module provides a way to measure Axcella Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axcella Health stock.
Axcella |
Axcella Health Company Revenue Analysis
Axcella Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Axcella Health reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Axcella Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axcella Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axcella Health could also be used in its relative valuation, which is a method of valuing Axcella Health by comparing valuation metrics of similar companies.Axcella Health is currently under evaluation in revenue category among its peers.
Axcella Fundamentals
| Return On Equity | -13.7 | |||
| Return On Asset | -0.88 | |||
| Current Valuation | 1.94 M | |||
| Shares Outstanding | 2.95 M | |||
| Shares Owned By Insiders | 15.77 % | |||
| Shares Owned By Institutions | 66.67 % | |||
| Number Of Shares Shorted | 78.18 K | |||
| Price To Earning | (1.10) X | |||
| Price To Book | 8.74 X | |||
| EBITDA | (67.01 M) | |||
| Net Income | (81.19 M) | |||
| Cash And Equivalents | 44.4 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 2.16 M | |||
| Debt To Equity | 3.02 % | |||
| Current Ratio | 2.69 X | |||
| Book Value Per Share | (0.77) X | |||
| Cash Flow From Operations | (69.59 M) | |||
| Short Ratio | 0.75 X | |||
| Earnings Per Share | (18.25) X | |||
| Target Price | 10.62 | |||
| Number Of Employees | 11 | |||
| Beta | 1.01 | |||
| Market Capitalization | 13.5 M | |||
| Total Asset | 18.93 M | |||
| Retained Earnings | (418.43 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 61.65 M | |||
| Current Liabilities | 6.16 M | |||
| Z Score | -38.64 | |||
| Net Asset | 18.93 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Axcella Stock
If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |